Boston Resident Diagnosed With Measles; Possible Exposure Locations Identified

BOSTON (CBS) – A Boston resident has the city’s first confirmed case of the measles since 2013. The Public Health Commission announced Wednesday that others may have been exposed at a number of locations in the South End, Fenway and Back Bay neighborhoods. Doctors diagnosed the case on Sunday. Health officials released the following lists of locations in Boston and times where the person could have exposed others: Friday, October 4th 1:30pm to 4:30pm Render Coffee, 563 Columbus Avenue, South End Friday, October 4th 2:30pm to 4:45pm Cafe Madeleine, 517 Columbus Avenue, South End Friday, October 4th 6:30pm to 9:30pm Gyroscope, 305 Huntington Avenue, Fenway Saturday, October 5th 11:30am to 1:35pm CouCou, 24 Union Park Street, South End Saturday, October 5th 12:00pm to 2:15pm Sir Speedy, 827 Boylston Street, Back Bay Anyone who was at those locations could get sick between Oct. 25 and Oct. 26, which is 21 days following the potential exposure. The commission said anyone who was exposed and isn’t sure of their immunization status or begins to develop measles symptoms should contact their healthcare provider. Those who have had the measles or received two doses of measles-containing vaccines are unlikely to get sick. Measles is very contagious and is usually spread through coughing and sneezing. It can stay in the environment for up to two hours after the infected person has left the area. Symptoms include a high fever, runny nose, cough and red eyes, followed by ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated Local Measles Source Type: news

Related Links:

[Monitor] Several health centres in Apac District at the weekend remained non-functional as health workers underwent orientation on how to administer rubella and measles vaccine on children.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Vanguard] Health authorities in the Democratic Republic of Congo will introduce a Johnson&Johnson Ebola vaccine in November in the country's eastern provinces, to counter the current outbreak, they said.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Did the introduction of pneumococcal conjugate vaccines help decrease the incidence of pneumococcal meningitis?Emerging Infectious Diseases
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Paul Farrell vows to make the opioid pill industry pay for what happened to Huntington.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
This brief primer reviews the pathophysiology of herpes zoster, and summarizes the results of the clinical trials of Shingrex, the newly approved recombinant vaccine for HZ prevention.Skin Therapy Letter
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
[Deutsche Welle] Many in the Democratic Republic of Congo have been waiting for this moment: A new vaccine to battle the Ebola outbreak is about to be released. The vaccine could reach broader parts of the population than before.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
In this study, structural proteins of MERS-CoV were expressed in silkworm larvae and Bm5 cells for the development of vaccine candidates against MERS-CoV and diagnostic methods. The spike (S) protein of MERS-CoV lacking its transmembrane and cytoplasmic domains (SοTM) was secreted into the hemolymph of silkworm larvae using a bombyxin signal peptide and purified using affinity chromatography. The purified SοTM forms small nanoparticles as well as the full-length S protein and has the ability to bind human dipeptidyl peptidase 4 (DPP4), which is a receptor of MERS-CoV. These results indicate that bioactive S...
Source: Journal of Biotechnology - Category: Biotechnology Source Type: research
Publication date: November 2019Source: Fish &Shellfish Immunology, Volume 94Author(s): Jing Wang, Jia-Jia Du, Biao Jiang, Run-Zhen He, An-Xing LiAbstractShort-term feed deprivation or fasting is commonly experienced by aquaculture fish species and may be caused by seasonal variations, production strategies, or diseases. To assess the effects of fasting on the resistance of Nile tilapia to Streptococcus agalactiae infection, vaccinated and unvaccinated fish were fasted for zero, one, three, and seven days prior to infection. The cortisol levels of both vaccinated and unvaccinated fish first decreased and then increased ...
Source: Fish and Shellfish Immunology - Category: Biology Source Type: research
Conclusion: SFTp is an uncommon benign neoplasm but it can have malignant features. Even in the case of recurrence, the main treatment is total surgical excision. Oncologic treatments can be tried in unresectable and metastatic cases. VATS can be used in surgical total excision for small diameter and appropriate tumors. Understanding the nature of these tumors, immunohistochemical, and genetic studies may be a guide in future.
Source: Nigerian Journal of Clinical Practice - Category: Rural Health Authors: Source Type: research
More News: Coffee | Conferences | Cough | Department of Health | Environmental Health | Eyes | Health | Huntington's Disease | International Medicine & Public Health | Measles | Measles Vaccine | Skin | Sports Medicine | Vaccines